NASDAQ:PFSA

Profusa (PFSA) Stock Price, News & Analysis

Profusa logo
$0.32 -0.02 (-6.40%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.33 +0.00 (+1.42%)
As of 11/20/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Profusa Stock (NASDAQ:PFSA)

Advanced

Key Stats

Today's Range
$0.31
▼
$0.35
50-Day Range
$0.32
▼
$3.03
52-Week Range
$0.31
▼
$1,516.50
Volume
162,965 shs
Average Volume
668,501 shs
Market Capitalization
$1.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Profusa is a medical technology company developing biosensors designed to measure changes in the body’s chemistry continuously. Its platform uses small, tissue-integrated sensors that generate signals a wearable reader can detect and relay for analysis.

The company’s Lumee Oxygen platform is designed to monitor oxygen levels in tissue. Profusa has focused on applications where local oxygen measurements may help clinicians assess tissue health, including care involving peripheral artery disease.

Profusa’s technology combines its biosensors with reader and software components to collect and display measurement data. The company is based in the United States and continues to develop its sensing platform for medical and other health-related applications.

AI Generated. May Contain Errors.

Profusa Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

PFSA MarketRank™: 
0.13818742985 of 5 stars

Profusa scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Profusa has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Profusa has only been the subject of 1 research reports in the past 90 days.

  • Read more about Profusa's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Profusa is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Profusa is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Profusa has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    19.13% of the float of Profusa has been sold short.
  • Short Interest Ratio / Days to Cover

    Profusa has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Profusa has recently increased by 26.55%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Profusa does not currently pay a dividend.

  • Dividend Growth

    Profusa does not have a long track record of dividend growth.

  • Search Interest

    Only 1 people have searched for PFSA on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Profusa insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.00% of the stock of Profusa is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    9.81% of the stock of Profusa is held by institutions.

  • Read more about Profusa's insider trading history.
Receive PFSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profusa and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PFSA Stock News Headlines

Your Copy is on Hold (Claim it now)
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel
Profusa Receives ISO 13485:2016 Certificate from GMED
Here’s What Investors Are Watching, Including $20 Price Target Bombshell
See More Headlines

PFSA Stock Analysis - Frequently Asked Questions

Profusa's stock was trading at $786.00 at the beginning of the year. Since then, PFSA shares have decreased by 100.0% and is now trading at $0.3234.

Profusa, Inc. (NASDAQ:PFSA) released its quarterly earnings data on Friday, November, 13th. The company reported ($6.23) EPS for the quarter.

Shares of Profusa reverse split before market open on Monday, February 9th 2026.The 1-75 reverse split was announced on Thursday, February 5th 2026. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 6th 2026. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of PFSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/13/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:PFSA
CIK
1859807
Fax
N/A
Employees
2
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($363.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$35.82 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-252.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.02
Quick Ratio
0.03

Sales & Book Value

Annual Sales
$100 thousand
Price / Sales
18.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.37 per share
Price / Book
0.24

Miscellaneous

Outstanding Shares
5,680,000
Free Float
4,830,000
Market Cap
$1.84 million
Optionable
N/A
Beta
0.62

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NASDAQ:PFSA) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners